Skip to content

Clinical trials

Observational Lung Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Phase: Observational Country / region: United States Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20014
20022
20031
20045
20056
20066
20071
20094
20114
20123
20134
20146
20153
20162
20176
20184
20193
20206
20218
20225
20236
20246
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed66
Recruiting16
Active, not recruiting11
Terminated6
Unknown status5
Enrolling by invitation3
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Weill Medical College of Cornell University7
University of Pittsburgh5
Columbia University4
National Institute of Environmental Health Sciences (NIEHS)4
AstraZeneca3
Johns Hopkins University3
National Institute of Allergy and Infectious Diseases (NIAID)3
University of California, San Diego3
University of North Carolina, Chapel Hill3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases110
Pulmonary Disease, Chronic Obstructive19
Asthma14
Lung Neoplasms9
Heart Diseases8
Lung Diseases, Interstitial8
Emphysema7
Respiratory Tract Diseases7
Neoplasms6
Pulmonary Fibrosis6

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.